Cargando…
Angiotensin II and TGF-β1 Induce Alterations in Human Amniotic Fluid-Derived Mesenchymal Stem Cells Leading to Cardiomyogenic Differentiation Initiation
BACKGROUND AND OBJECTIVES: Human amniotic fluid-derived mesenchymal stem cells (AF-MSCs) may be a valuable source for cardiovascular tissue engineering and cell therapy. The aim of this study is to verify angiotensin II and transforming growth factor-beta 1 (TGF-β1) as potential cardiomyogenic diffe...
Autores principales: | Gasiūnienė, Monika, Petkus, Gintautas, Matuzevičius, Dalius, Navakauskas, Dalius, Navakauskienė, Rūta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Stem Cell Research
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657950/ https://www.ncbi.nlm.nih.gov/pubmed/31023001 http://dx.doi.org/10.15283/ijsc18126 |
Ejemplares similares
-
Comparative Proteomic Assessment of Normal vs. Polyhydramnios Amniotic Fluid Based on Computational Analysis
por: Navakauskienė, Rūta, et al.
Publicado: (2022) -
The Effect of Angiotensin II, Retinoic Acid, EGCG, and Vitamin C on the Cardiomyogenic Differentiation Induction of Human Amniotic Fluid-Derived Mesenchymal Stem Cells
por: Gasiūnienė, Monika, et al.
Publicado: (2020) -
Epigenetic changes during hematopoietic cell granulocytic differentiation – comparative analysis of primary CD34+ cells, KG1 myeloid cells and mature neutrophils
por: Navakauskienė, Rūta, et al.
Publicado: (2014) -
Osteogenic Differentiation of Human Amniotic Fluid Mesenchymal Stem Cells Is Determined by Epigenetic Changes
por: Glemžaitė, Monika, et al.
Publicado: (2016) -
Comparison of the Cardiomyogenic Potency of Human Amniotic Fluid and Bone Marrow Mesenchymal Stem Cells
por: Jain, Manali, et al.
Publicado: (2019)